Skip to main content

Table 3 Multivariable analysis for overall survival

From: The impact of Karnofsky performance status on prognosis of patients with hepatocellular carcinoma in liver transplantation

 

HR (95%CI)

P value

Recipient age

1.02 (1.01–1.03)

< 0.001

KPS (ref. I)

 

< 0.001

 KPS II

1.16 (1.05–1.28)

0.004

 KPS III

1.53 (1.26–1.87)

< 0.001

Candidate race (ref. White)

 

0.032

 Black or African American

1.16 (0.10–1.35)

0.058

 Asian

0.77 (0.62–0.96)

0.021

 Hispanic/Latino

0.97 (0.85–1.12)

0.714

 Other

0.89 (0.55–1.44)

0.645

Sum of tumor diameter

1.06 (1.04–1.08)

< 0.001

Pre-transplant AFP

2.20 (1.76–2.76)

< 0.001

Donor ABO (ref. A)

 

0.022

 B

0.86 (0.73–1.01)

0.058

 O

1.08 (0.97–1.20)

0.146

 AB

0.91 (0.69–1.21)

0.527

Donor age

1.01 (1.00–1.01)

< 0.001

  1. AFP: Alpha-fetoprotein; BMI: body mass index; HR: hazard ratio; KPS: Karnofsky Performance Status